Autologous Platelet-rich Plasma Versus Whole Blood for Epidural Patch in Spontaneous Intracranial Hypotension

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorBeijing Tiantan Hospital

About this trial

Spontaneous intracranial hypotension (SIH) is a condition characterized by refractory orthostatic headache, mostly due to leaks of cerebrospinal fluid (CSF). Epidural patch with autologous platelet-rich plasma (PRP), which contains numerous growth factors and cytokines, has been reported as a new and promising alternative for current standard whole blood patching. However, there is no study comparing the efficacy and safety of the two approaches. In this study, we aimed to provide data concerning the outcomes of PRP patching versus conventional whole blood patching for treatment of refractory SIH cases failing in conservative therapy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Informed consent to participate the research obtained from the patient

Satisfies the criteria for SIH according to the International Classification of Headache Disorders.

Disqualifiers

There was concern for other causes of intracranial hypotension, such as postdural puncture, postsurgical and post-traumatic CSF leaks

Prior treatment with EBP at any time previously

Any contraindication to epidural puncture, such as space-occupying intracranial or intraspinal lesions, spinal defect, suspected infection over the puncture site, bleeding disorder and current anticoagulation therapy

History of drug and alcohol abuse, cognitive dysfunction, or mental illness

Trial design

Design model

Parallel

Treatments tested in this trial

  • PRP Patch group

    Procedure/Surgery

    Autologous PRP was prepared with the 2-stage centrifugation method and mixed with iohexol contrast. We chose two separate sites for epidural access. A standard epidural puncture was conducted under the guidance of CT. The PRP mixture was titrated slowly into the epidural space and must be stopped immediately to patient's perception of backache or irradiating pain. A strict bed stay for 48 h was prescribed in supine position postoperatively.

  • Whole Blood Patch Group

    Procedure/Surgery

    Autologous whole blood was prepared and mixed with iohexol contrast. We chose two separate sites for epidural access. A standard epidural puncture was conducted under the guidance of CT. The whole blood mixture was titrated slowly into the epidural space and must be stopped immediately to patient's perception of backache or irradiating pain. A strict bed stay for 48 h was prescribed in supine position postoperatively.

Treatment groups

218 Participants
are divided into 2 treatment groups
Group A: PRP Patch (PP)Experimental treatment 1 intervention
Group B: Whole blood patch (WP)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

The complete relief rate of patients with SIH

The complete relief was defined as the pain intensity of 0-1/10 on NRS or/and minimal symptoms post-procedurally.

Time frame
At 3 months after first epidural patch

Secondary outcomes

1

Pain intensity of orthostatic headache

Pain intensity was evaluated by pain numeric rating scale (NRS; 0 = no pain, 10 = unbearable pain).

Time frame
At 48 hours, 2 weeks, 3 and 6 months after first epidural patch
2

The complete relief rate of patients with SIH

The complete relief was defined as the pain intensity of 0-1/10 on NRS or/and minimal symptoms post-procedurally.

Time frame
At 48 hours, 2 weeks and 6 months after first epidural patch
3

The good response rate of patients with SIH.

Good response was defined as a headache reduction of at least 50%, with improvement of orthostatic component post-procedurally.

Time frame
At 48 hours, 2 weeks, 3 and 6 months after first epidural patch
4

The failure rate in each group.

Failure was defined as a persistent or worsening symptom with less than 50% of headache reduction within 72 hour post-procedurally.

Time frame
At 6 months after first epidural patch

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: